Johnson & Johnson Acquires Intra-Cellular in $14.6 Billion Deal
Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...
Joplin Globe12d
Smart Meter Remote Patient Monitoring Achieves Remarkable Growth and Expansion
Smart Meter, the leading technology and infrastructure supplier to the remote patient monitoring (RPM) industry, is thrilled to announce significant milestones in its growth trajectory. Since 2022, ...
U.S. News & World Report12d
J&J Buys Intra-Cellular in $14.6 Billion Deal, Delving Further Into Central Nervous System Disorders
J&J Buys Intra-Cellular in $14.6 Billion Deal, Delving Further Into Central Nervous System Disorders Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...